(Q44368149)

English

Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver

scientific article published in February 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

author name string

J Reichen

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

L Bianchi

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

P C Frei

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

P J Malé

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

D Lavanchy

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

M Schmid

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 February 1994

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

168-174

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in chronic hepatitis B. An analysis of 379 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The 30-minute aminopyrine breath test: optimization of sampling times after intravenous administration of 14C-aminopyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon-induced changes in chronic hepatitis B disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980054-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(05)80054-6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44368149&oldid=2020173219"